Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Net revenues	$ 28	$ 12	$ 35	$ 25
Operating expenses:
Direct costs of revenues	31		31
Research and development	104	333	269	642
Management contingent share plan expense	8	648	41	1,412
Impairment of intangible assets and cloud computing arrangements		2,633		2,633
Selling, general and administrative expenses	1,474	4,003	2,462	10,335
Total operating expenses	1,617	7,617	2,803	15,022
Loss from operations	(1,589)	(7,605)	(2,768)	(14,997)
Change in fair value of warrant liability		208	8	208
Loss from PIK Note Amendment and 2022 Debenture Release		(3,521)		(3,521)
Interest expense	(542)	(492)	(843)	(717)
Other (expense) income	(33)	117	(65)	95
Total non-operating expense	(575)	(3,688)	(900)	(3,935)
Loss before income taxes	(2,164)	(11,293)	(3,668)	(18,932)
Provision for income taxes
Net loss	(2,164)	(11,293)	(3,668)	(18,932)
Noncontrolling interest	1		1
Net loss attributable to FOXO	(2,163)	(11,293)	(3,667)	(18,932)
Deemed dividends related to the Exchange Offer and extension of and trigger of down round provisions of Assumed Warrants	(310)	(2,466)	(966)	(2,466)
Net loss to common stockholders	$ (2,473)	$ (13,759)	$ (4,633)	$ (21,398)
Common Class A [Member]
Operating expenses:
Net loss per share of Class A common stock, basic	$ (0.24)	$ (4.87)	$ (0.48)	$ (8.31)
Net loss per share of Class A common stock, diluted	$ (0.24)	$ (4.87)	$ (0.48)	$ (8.31)
Weighted average shares of Class A common stock, basic	10,341	2,827	9,629	2,574
Weighted average shares of Class A common stock, diluted	10,341	2,827	9,629	2,574